• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 10, Issue 1
  3. Author

Online ISSN: 2515-8260

Volume10, Issue1

Correlation of maternal serum glycosylated fibronectin in pre-eclampsia

    Dr. Rupakala B.M, Dr. Rahul Sreekumar

European Journal of Molecular & Clinical Medicine, 2023, Volume 10, Issue 1, Pages 3427-3434

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

To assess the correlation of maternal serum glycosylated fibronectin level in preeclamptic pregnant women with severity of pre-eclampsia.
Methods: An 18-month prospective study was conducted at the Rajarajeshwari Medical College and Hospital (RRMCH), Bengaluru, in the department of obstetrics and gynaecology (Jan 2021 – May 2022). Twenty-five preeclamptic pregnant women ≥20 weeks gestation made up the anticipated sample size. The LumellaTM PE test gadget was used to perform the maternal serum GlyFN test using the GlyFN POC device (from DiabetOmics, Inc.).
Results: There was statistically significant difference in severe pre-eclampsia between <=350 and >350 serum fibronectin values (P value <0.05). There were 93.75% (15 out of 16) severe pre-eclampsia cases in >350 serum fibronectin group where it was only 6.25% in <=350 group.
Conclusion: GlyFn POC test is a promising biochemical marker for severity of preeclampsia, and may be a useful adjunctive tool for rapid and accurate triage and intervention.
Keywords:
    biomarker glycosylated fibronectin point-of-care preeclampsia
  • PDF (321 K)
  • XML
(2023). Correlation of maternal serum glycosylated fibronectin in pre-eclampsia. European Journal of Molecular & Clinical Medicine, 10(1), 3427-3434.
Dr. Rupakala B.M, Dr. Rahul Sreekumar. "Correlation of maternal serum glycosylated fibronectin in pre-eclampsia". European Journal of Molecular & Clinical Medicine, 10, 1, 2023, 3427-3434.
(2023). 'Correlation of maternal serum glycosylated fibronectin in pre-eclampsia', European Journal of Molecular & Clinical Medicine, 10(1), pp. 3427-3434.
Correlation of maternal serum glycosylated fibronectin in pre-eclampsia. European Journal of Molecular & Clinical Medicine, 2023; 10(1): 3427-3434.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 10
  • PDF Download: 11
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus